Literature DB >> 10497165

Inositol 1,4,5-trisphosphate-independent Ca(2+) mobilization triggered by a lipid factor isolated from vitreous body.

J P Camiña1, X Casabiell, F F Casanueva.   

Abstract

A complex phospholipid from bovine vitreous body with a strong Ca(2+)-mobilizing activity has been recently isolated to homogeneity by our group. In this work, a sequential analysis of its transmembrane signaling pathway has been undertaken to characterize the intracellular mechanisms responsible for the Ca(2+) rise. The results show that this phospholipid induces, in a dose-dependent manner (ED(50) of around 0.25 microgram/ml), a Ca(2+) mobilization from inositol 1,4,5-trisphosphate-insensitive intracellular stores, with no participation of extracellular Ca(2+). Upon repeated administration, it shows no signs of autologous desensitization, does not induce heterologous desensitization of the L-alpha-lysophosphatidic acid (LPA) receptor but is desensitized by the previous administration of LPA. The Ca(2+)-mobilizing activity requires a membrane protein, is blocked after preincubation of the cells with pertussis toxin and phorbol esters, as well as by U73122 (an inhibitor of phospholipases C/D), R59022 (a diacylglycerol kinase inhibitor), and D609 (which inhibits phosphatidylcholine-specific phospholipase C). Upon administration of this phospholipid, the intracellular levels of phosphatidic acid (PA) rise with a time course that parallels that of the Ca(2+) mobilization, suggesting that PA could be responsible for this Ca(2+) signal. Exposure to AACOCF(3) (a specific inhibitor of phospholipase A(2)) does not modify the Ca(2+) rise, ruling out the possibility that the PA generated could be further converted to LPA by the action of phospholipase A(2). Based on the experimental data obtained, a signaling pathway involving a phosphatidylcholine-specific phospholipase C coupled to diacylglycerol kinase is proposed. This compound may represent a new class of bioactive lipids with a putative role in the physiology of the vitreous body.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497165     DOI: 10.1074/jbc.274.40.28134

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Mechanisms of leukotriene D4-induced constriction in human small bronchioles.

Authors:  V A Snetkov; K J Hapgood; C G McVicker; T H Lee; J P Ward
Journal:  Br J Pharmacol       Date:  2001-05       Impact factor: 8.739

2.  ICAM-1 signal transduction in cells stimulated with neutrophil elastase.

Authors:  Kohjiroh Ishihara; Yasuo Yamaguchi; Shinichiro Uchino; Takashi Furuhashi; Shinwa Yamada; Shinichi Kihara; Katsutaka Mori; Michio Ogawa
Journal:  Dig Dis Sci       Date:  2006-10-06       Impact factor: 3.199

3.  Inflammation and insulin resistance induced by trans-10, cis-12 conjugated linoleic acid depend on intracellular calcium levels in primary cultures of human adipocytes.

Authors:  Arion Kennedy; Kristina Martinez; Soonkyu Chung; Kathy LaPoint; Robin Hopkins; Soren F Schmidt; Kenneth Andersen; Susanne Mandrup; Michael McIntosh
Journal:  J Lipid Res       Date:  2010-02-14       Impact factor: 5.922

4.  Ion transport regulated by protease-activated receptor 2 in human airway Calu-3 epithelia.

Authors:  Shinji Sato; Yasushi Ito; Masashi Kondo; Takamasa Ohashi; Satoru Ito; Shinsuke Nakayama; Kaoru Shimokata; Hiroaki Kume
Journal:  Br J Pharmacol       Date:  2005-10       Impact factor: 8.739

5.  Growth hormone-releasing hormone as an agonist of the ghrelin receptor GHS-R1a.

Authors:  Felipe F Casanueva; Jesus P Camiña; Marcos C Carreira; Yolanda Pazos; Jozsef L Varga; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-16       Impact factor: 11.205

6.  Diacylglycerol kinase inhibitor R59022 attenuates conjugated linoleic acid-mediated inflammation in human adipocytes.

Authors:  Kristina Martinez; Shruthi Shyamasundar; Arion Kennedy; Chia Chi Chuang; Angel Marsh; Jennifer Kincaid; Tanya Reid; Michael McIntosh
Journal:  J Lipid Res       Date:  2012-12-22       Impact factor: 5.922

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.